Vensun Pharmaceuticals is recalling approximately 15,335 bottles of Potassium Citrate Extended-Release Tablets (potassium citrate) because the tablets may break or crumble. This recall affects 100-count bottles of both 10 mEq and 15 mEq strengths that were distributed across the United States and Puerto Rico. When an extended-release tablet breaks, it can interfere with how the medication is absorbed by the body, potentially leading to serious health complications. Consumers should check their prescription bottles immediately to see if their medication is part of the affected lots.
Broken extended-release tablets can cause the medication to be released into the bloodstream all at once rather than slowly over time. This 'dose dumping' can lead to dangerously high levels of potassium in the blood or cause irritation and injury to the digestive tract.
Return for refund and medical consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.